Results 131 to 140 of about 12,914,892 (258)

Z score neurofeedback : clinical applications /

open access: yes
Neurofeedback is utilized by over 10,000 clinicians worldwide with new techniques and uses being found regularly. Z Score Neurofeedback is a new technique using a normative database to identify and target a specific individual's area of dysregulation ...
Lubar, Joel F.,editor.   +2 more
core  

Zerstörung Jerusalems. Vocal score. English & German

open access: yes, 2012
1 vocal score (vii, 248 p.) ; 27 cm. English and German words; also printed as text on p.
Steinheim, Salomon Ludwig   +1 more
core  

F-score of six datasets timewise predictions.

open access: yes
The performance of the defect prediction model by using balanced and imbalanced datasets makes a big impact on the discovery of future defects. Current resampling techniques only address the imbalanced datasets without taking into consideration ...
Ahmad Muhaimin Ismail (18349752)   +3 more
core   +1 more source

Area under the curve (AUC) of the fibrosis-based activity score (F-score), Mohamadnejad et al. score (M-score), and LSM-based activity score (L-score) in differentiating significant inflammation.

open access: yes, 2014
(A) AUC of the F-Score and M-Score for the HBeAg(+) patients in the training set; (B) AUC of the F-Score and M-Score in the HBeAg(−) patients in the training set; (C) AUC of the F-Score, M-Score, and L-Score in the HBeAg(+) patients in the validation set;
Guo-Liang Chen (652632)   +7 more
core   +1 more source

Metastasis on pause: How dormant tumor cells stay hidden within the tumor microenvironment and evade immune surveillance

open access: yesMolecular Oncology, EarlyView.
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary   +1 more
wiley   +1 more source

Mean F-score for three frequency ranges.

open access: yes, 2012
Mean F-score for three frequency ranges.
Johan Högberg (142073)   +5 more
core   +1 more source

Evaluating Continuous Training Programs Using the Generalized Propensity Score [PDF]

open access: yes
This paper assesses the dynamics of treatment effects arising from variation in the duration of training. We use German administrative data that have the extraordinary feature that the amount of treatment varies continuously from 10 days to 395 days (i.e.
Jochen Kluve   +3 more
core   +2 more sources

Relationship between preoperative body composition parameters and postoperative clinical score for rotator cuff tear patients

open access: yesJSES International
Background: Various intrinsic and extrinsic factors have been reported for rotator cuff tears (RCTs). This study aimed to assess the relationship between preoperative body composition parameters and postoperative clinical score in patients who underwent ...
Naoki Takatori, MD, PhD   +4 more
doaj   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy